4th ISN Latin American School of Advanced Neurochemistry Organizes First Symposium on Medical Cannabis

The endocannabinoid system is finally being recognized at high impact scientific events.

Montevideo, Uruguay – November 03, 2017 – “Brain Pathologies and Natural Products” by the 4th ISN Latin American School of Advanced Neurochemistry hosted the first symposium on medical Cannabis, which was held in Montevideo, Uruguay on October 28th, 2017 organized and directed by Dr. Cecilia Scorza from the IIBCE and Dr. Raquel Peyraube, President of SUEN (Uruguayan Endocannabinology Society).

“We are proud of the results that were achieved. We are motivated to move forward with our newly founded scientific association that will primarily focus on spreading the latest findings regarding the endocannabinoid system to doctors and healthcare professionals in Uruguay,” said Dr. Raquel Peyraube, President of SUEN.

“A great success that can push cannabis treatment forward,” said Prof. Dr. Lumír Ondřej Hanuš, keynote speaker of the event.

Dr. Xavier Nadal, Director of the Extraction Department of Phytoplant Research S.L., focused his presentation on Opioid and Cannabinoid Interactions. Dr. Nadal presented an update on the clinical benefits and risks of using medical cannabis to fight the opioid epidemic. As an exclusive sponsor of the mini-symposium, Phytoplant Research S.L has a strong scientific focus in the field of cannabinoid research. They are generating preclinical and clinical data to better understand the potential medical benefit of cannabis and how it can be used to treat serious and life-threatening diseases.

Download the poster of the event here.

About the 4th ISN Latin American School of Advanced Neurochemistry:

The purpose of the 4th ISN Latin American School of Advanced Neurochemistry is to provide an update on the theoretical background of brain pathologies and the neurochemical experimental approaches used for their study, with a special emphasis on the potential beneficial and deleterious effects of natural products. More information about it is available here.

 

About the Uruguayan Endocannabinology Society (SUEN):

The Uruguayan Endocannabinology Society was founded on May 15, 2017, in the city of Montevideo. Its main objectives are to disseminate knowledge and advances in endocannabinology in academic areas and in the general population, promote education and research in endocannabinology, and access to treatments based on cannabis and cannabinoids that benefit health, always from the deep respect of Human Rights and the principles of Medical Ethics and Public Health. The membership is about 30 professionals. SUEN has its physical headquarters in the facilities of the Medical Union of Uruguay. More information about it is available here.

 

About Phytoplant Research S.L:

Phytoplant Research S.L. is a privately owned Spanish company founded in 2008 and active in the field of phytotherapy research. It specializes in developing the industrial chain of medicinal plants, from selection and breeding to registration, cultivation of registered varieties and obtaining derived products. The company focuses on R&D products that contain plant material and extracts, as well as essential and seed oils. These products represent significant economic potential for the pharmaceutical, nutraceutical and dermocosmetic industries. They also ensure the industrial supply of phyto-pharmaceutical quality raw materials through the cultivation of medicinal plants and extraction of plant material, with the objective of isolating, purifying and manufacturing naturally active ingredients (psychotropic and non-psychotropic), semi-synthetic, biotransformed, pharmaceutically acceptable salts and derivatives. More information about Phytoplant Research S.L. is available here.

 

Media Contact:

Name: Stefan Martin Meyer, CEO

Phone: (0034) 957 10 16 29

Email: media@phytoplant.es